Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 8Hodgkin Disease 6Central Nervous System Neoplasms 4Oligodendroglioma 3Glioma 2Brain Neoplasms 2Astrocytoma 2Radiation Injuries 1Optic Nerve Glioma 1Neurotoxicity Syndromes 1Lymphoma, AIDS-Related 1HIV Infections 1

Interventions

Polymerase Chain Reaction 5Watchful Waiting 2Taxes 2Paclitaxel 2Light Coagulation 2Imiquimod 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Gene Expression Profiling 2Fluorouracil 2Flow Cytometry 2Etoposide 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Biopsy 2nirogacestat 1fludarabine 1emvododstat 1carmustine, poliferprosan 20 drug combination 1axicabtagene ciloleucel 1Vorinostat 1Vincristine 1Vinblastine 1Sodium Chloride 1Smoking Devices 1Restraint, Physical 1Remote Patient Monitoring 1Radiotherapy 1Radiation 1Procarbazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × HIV Infections × Procarbazine × Clear all
NCT00822120 2022-08-18

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

SWOG Cancer Research Network

Phase 2 Completed
371 enrolled 14 charts
Lymphoid

Hodgkin Disease, Lymphoma, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡